NASDAQ: MXCT
Maxcyte Inc Stock Ownership - Who owns Maxcyte?

Insider buying vs selling

Have Maxcyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Douglas J. SwirskyCHIEF FINANCIAL OFFICER2025-03-186,939$3.18
$22.06kSell
David I. SandovalGENERAL COUNSEL2025-03-18353$3.18
$1.12kSell
Ali SoleymannezhadChief Commercial Officer2025-03-181,211$3.18
$3.85kSell
John Joseph JohnstonDirector2025-01-273,000$2.93
$8.80kBuy
John Joseph JohnstonDirector2025-01-273,000$4.65
$13.93kSell
David I. SandovalGENERAL COUNSEL2025-01-134,466$4.54
$20.27kSell
John Joseph JohnstonDirector2024-12-263,000$2.93
$8.80kBuy
John Joseph JohnstonDirector2024-12-263,000$4.01
$12.02kSell
John Joseph JohnstonDirector2024-12-09483$2.93
$1.42kBuy
John Joseph JohnstonDirector2024-12-09891$2.93
$2.61kBuy

1 of 5

MXCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MXCT insiders and whales buy or sell their stock.

MXCT Shareholders

What type of owners hold Maxcyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Casdin Partners Master Fund LP9.43%10,000,000$29.10MInsider
Cadian Capital Management LP8.81%9,344,424$27.19MInstitution
Blackrock Inc7.57%8,023,440$23.35MInstitution
Vanguard Group Inc5.12%5,429,681$15.80MInstitution
Vitruvian Partners LLP4.76%5,043,356$14.68MInstitution
Morgan Stanley4.16%4,408,253$12.83MInstitution
Mirabella Financial Services LLP3.49%3,700,000$10.77MInstitution
River Global Investors LLP3.07%3,253,192$9.47MInstitution
Mudita Advisors LLP3.04%3,223,407$9.38MInstitution
Fmr LLC2.96%3,136,771$9.13MInstitution

1 of 3

MXCT vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MXCT68.36%11.36%Net BuyingNet Selling
SMLR47.19%52.81%Net Buying
NNOX21.54%0.00%
VMD63.49%12.97%Net SellingNet Selling
PACB87.14%7.80%Net SellingNet Selling

Maxcyte Stock Ownership FAQ

Who owns Maxcyte?

Maxcyte (NASDAQ: MXCT) is owned by 68.36% institutional shareholders, 11.36% Maxcyte insiders, and 20.28% retail investors. Casdin Partners Master Fund LP is the largest individual Maxcyte shareholder, owning 10.00M shares representing 9.43% of the company. Casdin Partners Master Fund LP's Maxcyte shares are currently valued at $28.40M.

If you're new to stock investing, here's how to buy Maxcyte stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.